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Diclofenac is a worldwide consumed drug included in the watch list of substances to be monitored 
according to the European Union Water Framework Directive (Directive 2013/39/EU). Aerobic granular 
sludge sequencing batch reactors (AGS-SBR) are increasingly used for wastewater treatment but there is 
scant information on the fate and effect of micropollutants to nutrient removal processes. An AGS-SBR 
fed with synthetic wastewater containing diclofenac was bioaugmented with a diclofenac degrading 
bacterial strain and performance and microbial community dynamics was analysed. Chemical oxygen 
demand, phosphate and ammonia removal were not affected by the micropollutant at 0.03 mM (9.54 mg 
L-1). The AGS was able to retain the degrading strain, which was detected in the sludge throughout after 
augmentation. Nevertheless, besides some adsorption to the biomass, diclofenac was not degraded by the 
augmented sludge given the short operating cycles and even if batch degradation assays confirmed that 
the bioaugmented AGS was able to biodegrade the compound. The exposure to the pharmaceutical 
affected the microbial community of the sludge, separating the two first phases of reactor operation 
(acclimatization and granulation) from subsequent phases. The AGS was able to keep the bioaugmented 
strain and to maintain the main functions of nutrient removal even through the long exposure to the 
pharmaceutical, but combined strategies are needed to reduce the spread of micropollutants in the 
environment. 
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1. Introduction 
In the last century, the growth of the global population and the increased life expectancy in developed 
countries have led to an increase in the consumption of pharmaceuticals [1]. These organic compounds 
are considered as emerging contaminants as they have the potential to enter in several compartments in 
the environment and cause adverse ecological and/or human health effects [2]. After metabolism and 
excretion, as unchanged compounds or as metabolites, in urine and/or faeces these micropollutants reach 
the wastewater treatment plants (WWTPs) through the sewage network [3]. Moreover, direct release may 
occur by improper dump of unused or expired drugs directly in toilet sinks or as solid waste. 
Conventional WWTPs are not designed to remove this kind of pollutants, which results in their release 
into the environment [4,5]. The existing physico-chemical removal processes (activated carbon, 
photolysis, radiation, advanced oxidation processes, ozone and chlorination) display some draw-backs as 
they are expensive and may result in unknown and potentially harmful by-products [2].  
In the latest revision of the Water Framework Directive (Directive 2013/39/EU) a revised watch list of 
substances to be monitored [6] in the field of water policy  has been proposed. It contemplates 17 organic 
compounds, including the nonsteroidal anti-inflammatory drug (NSAID) Diclofenac (2-(2-(2,6-di-
chlorophenylamino) phenyl)acetic acid). NSAIDs are of great concern due to their wide administration in 
humans and animals to treat inflammation and as pain relievers [7], being the largest group of over-the-
counter drugs sold worldwide.  Diclofenac is generally considered as a Contaminant of Emerging 
Concern (CEC), is one of the most persistent pharmaceuticals in the environment, and is removed with 
very low  efficiency  in WWTP [8]. Vieno and Sillanpää [7] reported mean concentrations of diclofenac 
in the influent of municipal WWTP between 0.11 and 2.3 µg/L and higher than 1 µg/L in the effluent. 
Higher concentrations of this compound at the effluent (up to 5.5 µg/L) than in the influent, due to DCF 
deconjugation during the WWTP treatment, have been reported [9].  
Aerobic granular sludge (AGS) technology is a growing biotechnology for the treatment of domestic and 
industrial wastewater [10]. The properties of AGS, such as excellent settling capacity due to compact and 
dense microbial structure, ability to perform simultaneously diverse biological processes (such as 
Chemical Oxygen Demand – COD, Nitrogen and Phosphate removal), resilience to toxicity due to the 
protection by a matrix of EPS, and long biomass residence time, confer advantages over more 
conventional wastewater treatments [11]. Further, the biomass immobilisation makes AGS prone to 
bioaugmentation [12]. Amorim et al.  [13] evaluated the performance of AGS-SBR exposed to three 
fluoroquinolones, namely ofloxacin, norfloxacin and ciprofloxacin and verified that the compounds were 
firstly adsorbed to the AGS, being subsequently released to the medium in the following cycles. A study 
conducted by Kent and Tay [14] concluded that the removal of 17α‑ ethinylestradiol, 4‑ nonylphenol and 
carbamazepine was initially carried by adsorption to AGS, transitioning to biodegradation when the 
active sites were saturated, indicating a sludge acclimatization to the contaminants. The ability of AGS-
SBR to degrade fluoxetine shock loadings was assessed by Moreira et al.  [15]. Overall, fluoxetine was 
firstly absorbed by AGS, followed by a desorption mechanism when the toxic compound was not present 
in the feed. The system proved to be robust towards fluoxetine shocks as it was able to resume its 
performance in terms of main biological processes after its feeding was ceased.  The acclimatization of 
the seed sludge with the target contaminant has been indicated as a key step for efficient biodegradation 
in AGS reactors. Several reports claimed the successful biodegradation of recalcitrant compounds, such 
as phenol, 2-chlorophenol, 2,4,6-trichlorophenol, 2,4-dichlorophenol and p-nitrophenol, by acclimatized 
AGS [16–20]. Bioaugmentation with degrading strains has also proven to be an efficient strategy for the 
degradation of persistent compounds by AGS,  including 2-fluorophenol, 2,4-dichlorophenoxyacetic acid 
and a mixture of chlorophenols and o-nitrobenzaldehyde [12,21,22]. 
In the present study an AGS-SBR bioaugmented with a bacterial strain - Labrys portucalensis F11- able 
to degrade pharmaceuticals, including diclofenac [23], was operated during 286 days intermittently 
supplied with diclofenac.  The main aim of this study was to assess the persistence of the degrading strain 
within the AGS and to evaluate the biodegradation of the micropollutant by the bioaugmented granules 
while measuring the overall performance of the bioreactor for main nutrient removal processes. The 
microbial community dynamics were evaluated. 
 2. Materials and methods 
2.1. Chemicals and materials 
Acetonitrile was purchased from Merck (Darmstadt, Germany). Trifluoroacetic acid (99%) and 
trimethylamine (≥99%) were obtained from Sigma-Aldrich (Steinheim, Germany). Ultrapure water was 
supplied by a Milli-Q Gradient A-10 (Millipore) system (18.2 MΩcm, organic carbon ≤ 4 μg/L). HPLC 
grade solvents were filtered with 0.45 µm Glass microfiber filters (Whatman™). Diclofenac sodium salt 
was purchased from Sigma-Aldrich (Steinheim, Germany). Stock standard solutions of diclofenac were 
filtered on syringe nylon membrane filters (0.22 µm pore-size in order to sterilize) to sterile amber bottles 
and stored at −20°C. Minimal salts medium (MM) [24] and SBR influent media [25]  were prepared with 
analytical-grade chemicals (Sigma–Aldrich Chemie, Steinheim, Germany; Merck, Darmstadt, Germany). 
Sodium acetate was purchased from Merck (Darmstadt, Germany). All other chemicals used in this study 
were analytical grade (Sigma-Aldrich Chemie, Steinheim, Germany; Merck, Darmstadt, Germany).   
2.2. Cultivation conditions 
Labrys portucalensis F11 (GenBank/EMBL/DDBJ accession number AY362040) was selected due to its 
proven biodegradation ability towards diclofenac [23]. To obtain the inoculum for bioreactor 
bioaugmentation, pure cultures of Labrys portucalensis F11 were grown in flasks with mineral salts liquid 
medium containing 5.9 mM of acetate and 0.03 mM of diclofenac, which biodegradation was confirmed. 
The cultures were incubated on an orbital shaker (120 rpm) at 25 °C. The optical density at 600nm 
(OD600) was followed to monitor the cellular growth.  
2.3. Reactor set up and operation 
An AGS-SBR operated at controlled temperature (20 ± 2°C) was set-up. The reactor was initially 
operated as a bubble column (Phase I, Table 1) with a working volume of 2.5 L (diameter 5.6 cm). The 
reactor inoculum consisted in a mixture of 0.8 L activated sludge from the aeration tank of the municipal 
WWTP of Parada (Maia, Portugal) and 1.0 L of pure culture of the bacterial strain Labrys portucalensis 
strain F11 with an OD600 of ca. 0.755. During phase I, a constant airflow of 4.0 L min
−1 (superficial gas 
velocity of 1.51 m min−1) was kept and periodic feedings were applied with acetate (5.9 mM) and 0.03 
mM of DCF (9.54 mg L-1) in order to establish a selective pressure on the seed sludge and to favor the 
maintenance of the degrading strain. Diclofenac concentration was higher than what is normally found in 
domestic effluents and was used to assess the capacity of the reactor of biodegrading the compound 
through bioaugmentation and to assess the robustness of the reactor even if exposed to higher levels. At 
day 20, the reactor operation conditions were changed to an SBR mode – Phase II. During this phase, the 
reactor was operated in a 3-h cycle time with a 60 min non-mixed anaerobic feeding period, 112 min 
aeration, and 5 min effluent withdrawal; settling time was gradually decreased from 30 min to 3 min. The 
volumetric exchange ratio was 0.56 with a hydraulic retention time of 5.4 h. The pH was measured with a 
pH electrode and maintained at 7.1 ± 0.1 by dosing either 1M NaOH or 1M HCl. The SBR influent media 
was supplemented with diclofenac at a final concentration of 0.03 mM (9.54 mg L-1). During phase III 
diclofenac was ceased from the influent feeding in order to evaluate the resilience of the bioaugmented 
strain and the system ability towards nutrient removal. The operating conditions for each phase are 
described in detail on Table 1. During the whole time, the bioreactor was protected from light in order to 
prevent photocatalytic degradation of diclofenac and algal growth.  
2.4. Analytical methods 
Bioreactor influent and effluent samples were regularly withdrawn and filtered through nylon membrane 
syringe filters (0.45 mm pore-size) to remove biomass. Phosphate, ammonia, nitrate and nitrite 
concentrations in the filtrate were determined using specific commercial photometric test kits 
(Spectroquant®, Merck Millipore, Massachusetts, EUA), according to manufacture instructions. Total 
suspended solids (TSS), volatile suspended solids (VSS), mixed liquor suspended solids (MLSS), mixed 
liquor volatile suspended solids (MLVSS) concentrations and sludge volume index (SVI) were 
determined according to Standard Methods [26]. The AGS bed volume was determined at the end of the 
settling period using a graduated scale placed on the reactor column. Diclofenac concentration was 
measured by HPLC according to a validated method previously described [27]. 
2.5. Sampling of aerobic granular sludge for microbial analysis and degradation assays 
AGS samples were collected from the reactor during aeration phase. Then, the granules were crushed 
using a sterile potter and pestle. The resulting bacterial suspensions were used for plating, degradation 
assays, bacterial identification and DNA extraction for DGGE analysis. Moreover, an AGS sample was 
taken during phase IV in order to establish batch assays to assess the capacity of the bioaugmented AGS 
to biodegrade diclofenac. 
2.6. Bacterial isolates from AGS-SBR 
During phases III and VI, AGS samples were collected for isolation of bacteria able to degrade 
diclofenac. Using the streak-plate technique, different bacterial colonies were isolated based on size, 
morphology and pigmentation. For each isolate, streaking onto agar plates containing 0.03 mM (9.54 mg 
L-1) diclofenac was made in order to evaluate their potential to grow in the presence of the 
pharmaceutical. For the isolates that had that ability, genomic DNA was extracted based on the heat-
shock extraction method. 
Bacterial isolates were grouped according to species similarity, based on Random Amplified Polymorphic 
DNA (RAPD) profiles, following the procedure described in Amorim et al.  [13]. Isolates displaying 
unique RAPD profiles were subsequently identified by 16S rRNA gene sequencing analysis. 
Amplification was performed with universal bacterial primers 27F and 1492R, as previously described 
[12]. The amplified fragments were sequenced by StabVida, Portugal. To determine the phylogenetic 
affiliation, similarity searches were performed using the BLAST program from the National Centre of 
Biotechnology Information website (http://www.ncbi.nlm.nih.gov/) 
Isolates with ability to grow in the presence of diclofenac were inoculated into MM containing 0.03 mM 
diclofenac as a sole carbon to evaluate the capacity to degrade the compound. Briefly, for each isolate 
(with an initial OD600 of ca. 0.05), 250 mL flasks containing 75 mL of a sterile MM supplemented with 
0.03 mM of diclofenac were established. Degradation was monitored for 30 days. Abiotic and adsorption 
control assays were established. In brief, abiotic controls consisted of sealed flasks containing MM 
supplemented with diclofenac; adsorption controls were conducted in flasks containing MM 
supplemented with DCF and inoculated with non-viable (i. e. autoclaved) cells of each isolate, separately. 
All the cultures were incubated at 25ºC on a rotary shaker (150 rpm). Experiments were performed in 
triplicate under sterile conditions and protected from light (to prevent photolytic degradation). Samples 
were taken at regular intervals to assess growth and diclofenac degradation. Purity of the cultures was 
evaluated through regular plating on NA plates.  
2.7. Total aerobic granular sludge microbial community analysis 
Genomic DNA from the crushed AGS samples was extracted using the UltraClean Microbial DNA 
Isolation Kit (MO BIO Laboratories, Inc., USA), according to the manufacturer’s instructions. The 
extracted DNA was kept at -20ºC. The PCR amplification of the highly variable V3 region of bacterial 
16S rRNA gene fragments and separation of PCR-amplified fragments by DGGE was performed as 
described in Amorim et al.  [13] using a DCodeTM Universal Mutation Detection System (Bio-Rad 
Laboratories, Richmond, CA, USA). DGGE profiles were analysed using Bionumerics software (Applied 
Maths, St-Martens-Laten, Belgium). Dendrograms were generated by Jaccard/UPGMA cluster analysis. 
Two different indexes were assessed using DGGE banding data: the Shannon’s diversity index (H) [28] 
was used to estimate the diversity of bacterial communities and the Equitability index (E) was used to 
evaluate the dominance between species. The Equitability index (E) can range from near 0, pronounced 
dominance, to near 1, complete evenness. Selected DGGE bands were excised and the DNA sequencing 
was performed according to Amorim et al.  [13]. Band sequences were compared using the BLAST 
software at the National Centre of Biotechnology Information website (http://www.ncbi.nlm.nih.gov/) for 
identification and phylogenetic classification. 
2.8. Aerobic granular sludge diclofenac degradation ability in batch conditions 
Diclofenac biodegradation ability of AGS was evaluated in culture flasks. The experiments were set up in 
250 mL flasks containing 80 mL of a sterile SBR influent medium with 5 g (wet weight) of AGS, 0.03 
mM (9.54 mg L-1) of the target compound and periodic feeding with 5.9 mM of acetate as a 
supplementary carbon source. All the cultures were incubated at 25ºC on a rotary shaker (150 rpm). 
Experiments were performed in triplicate under sterile conditions and protected from light. Abiotic and 
adsorption controls were also established. The biodegradation was monitored for 30 days. 
3. Results and discussion 
Diclofenac is a micropollutant of environmental concern frequently detected in wastewater influents, in 
this context is important to evaluate the fate and effect of this contaminant in wastewater treatment 
processes. In phase I, the reactor was inoculated with activated sludge from a municipal WWTP and the 
bacterial strain Labrys portucalensis F11, and operated as a bubble column for the acclimatization of the 
biomass to diclofenac. During phase II, the reactor operation conditions were changed to an SBR mode 
for the granulation process to occur. During phase III, diclofenac was not supplied in the influent feeding. 
In phases IV and V, the diclofenac was fed in intermittent mode, using different cycles’ length. 
Diclofenac feeding was ceased in phase V. The fate of diclofenac and its effects on main biological 
processes COD-, N- and P-removal, and on the granular biomass properties and microbial community, 
were evaluated. 
3.1. AGS-SBR performance 
3.1.1. Carbon and nutrient removal  
During phase I the biomass was acclimatized to diclofenac. During phases II and III, with and without 
diclofenac respectively, a stable COD removal was observed, with almost all COD consumed during the 
anaerobic feeding phase (data not shown). After resuming diclofenac supplementation, during phases IV 
to VI, COD concentration after the feast period was low (30 mgO2 L
-1 in average), indicating that the 
presence of diclofenac did not affect COD uptake (Fig 1a). Throughout the entire SBR operation the COD 
removal efficiency remained very stable, always far below the emission limit value established by the 
European Commission of 125 mg O2 L
-1 (council directive 91/271/EEC), with almost complete uptake 
during anaerobic phase. Some previous studies on pharmaceutical compounds had reported similar results 
in terms of overall COD removal, showing that AGS is capable of maintaining its performance in the 
presence of this kind of compounds. Amorim et al.  [13] noticed a decrease in COD uptake when 
fluoroquinolones were present in the inlet stream, but the COD effluent quality was unaffected. Another 
study with AGS also reported that although COD removal effeciency was temporarily affected by the 
presence of chiral pharmaceuticals, the reactor was able to resume activity after ceasing the supply of 
pharmaceuticals, indicating a fast recovery of the AGS [29]. Kent and Tay  [14] observed a stable COD 
removal efficiency (in average > 92%) in an AGS-SBR established for the treatment of 
17α‑ ethinylestradiol, 4‑ nonylphenol, and carbamazepine, with all of the three compounds being 
degraded, although carbamazepine to a lower extend. Moreira et al.  [15] also noted that the presence of 
fluoxetine in the inlet feeding of an AGS-SBR did not compromise the COD removal as low COD 
concentrations on the effluent were observed. 
One of the several advantages of the AGS-SBR technology is the ability of simultaneous N and P removal  
[30]. The phosphate (Fig 1b) concentration in the medium was 20 mg L-1 PO4
3-- P and after the anaerobic 
feeding period this was raised to around 40 mg L-1 PO4
3-P; the effluent had ca 4.6 mg L-1 of PO4
3-- P. This 
trend was observed in all phases of the experimental period.  An example of the [PO4
3-P] (mg L-1) 
concentration profile along the AGS-SBR operation (Phase V) is given in Fig 2a. The levels of phosphate 
released into the bulk medium during the feast period and the uptake during the famine period were in 
accordance with phosphate accumulating organisms’ metabolism, indicating that the presence of 
diclofenac did not affect it. Different emerging contaminants may exert a variety of responses on the 
metabolism of these microorganisms. The present results are different from previous reports where the 
presence of other pharmaceutical compounds inhibited the phosphate release during anaerobic phase, 
although not interfering with its uptake during aerobic phase, resulting in good removal efficiencies 
[14,15,31].  
Regarding the nitrogen removal process, the ammonium concentration detected in the SBR after 1hr 
feeding was within the theoretically expected range, considering the dilution factor (8.62 mg L-1 of NH4
+-
N, in average) and ammonium was almost fully removed (0.5 mg L-1 NH4
+ - N, in average in the effluent) 
during all reactor operation period, indicating a highly efficient nitrification (Fig 1c). This indicates that 
ammonia oxidizing bacteria were not affected by the presence of diclofenac throughout the entire 
operation of the reactor. Other reports also showed that ammonia oxidation was a stable process in the 
presence of pharmaceuticals [13,14], indicating the potential of AGS towards this process in the presence 
of micropollutants. During phase V, a fluctuation in ammonium inlet concentration was observed, which 
did not affect its removal. From day 194 until day 233 (Phase IV and beginning of Phase V), nitrite was 
present both during famine period and in the treated effluent with an average concentration of 15 mg L-1 
of NO2
--N and 10 mg L-1 of NO2
--N, respectively (Fig 1d) with higher values detected from days 229 to 
233 in the effluent, probably indicating a disturbance in nitrite to nitrate conversion (nitrite oxidizing 
bacteria metabolism) due to the re-introduction of diclofenac feeding. From day 236 until the end of the 
SBR operation, nitrite concentration, both in aeration phase and the treated effluent, was very low (0.59 
mg L-1 of NO2
--N), indicating a recovery in nitrite oxidizing bacteria metabolism. As seen in Fig 1e, from 
day 229 until the end of the bioreactor operation, the amount of nitrate in the effluent (up to 37.8 mg L-1 
of NO3




(all in mg L-1) concentration profiles, representing a typical cycle with diclofenac (from day 194 until day 
233) and a cycle after diclofenac feeding stopped (from days 236 until the end of AGS-SBR operation). 
Although some studies report the sensibility of the nitrifying bacteria towards toxic compounds, such as 
chiral pharmaceuticals, fluoxetine and tetracycline [15,31,32], in the current study ammonia oxidizing 
bacteria were not affected and nitrite oxidizing bacteria demonstrated its ability of adaptation to the 
micropollutant. 
3.1.2. Fate of diclofenac 
The AGS bioreactor was not able to significantly reduce the diclofenac concentration. The DCF 
concentration used is higher than that normally found in wastewaters [7,9], but in the same range of those 
used in other studies on the removal of this pharmaceutical [33]. This concentration was chosen to 
promote a selective pressure that would favor the persistence of the degrading strain and of a microbial 
community adapted to the presence of the pharmaceutical within the bioaugmented granules. In Fig 3, 
diclofenac (mg L-1) concentration profile along an AGS-SBR cycle (Phase V) is shown. During each 
cycle ca 15% of the compound was retained with AGS, possibly through adsorption to the granules (Fig. 
3), indeed in subsequent cycles without diclofenac feeding desorption accounted for all diclofenac fed 
into the bioreactor. Adorption/desorption mechanism onto AGS has been reported for pharmaceutical 
compounds, namely fluoroquinolones [34], although with those compounds adsorption was stronger. 
Fluoroquinolones were also evaluated in an AGS-SBR by Amorim et al.  [13], where the compounds 
were firstly adsorbed to the AGS, and subsequently released to the medium in the following cycles. In the 
present study, diclofenac followed an adorption/desorption mechanism onto AGS, which prevailed over 
potential biodegradation. Labrys portucalensis F11 is a strictly aerobic bacterium, and it may be that the 
long anaerobic feeding process may slow down its metabolism. Although strain Labrys portucalensis F11 
is able to degrade diclofenac as a sole carbon source, degradation is enhanced in the presence of acetate 
[23]. In the reactor, all acetate was consumed during the anaerobic phase which may have further limited 
the activity of Labrys portucalensis F11 preventing cometabolic degradation of diclofenac. The aeration 
time in each cycle was not sufficient for significant degradation of the pharmaceutical compound. In a 
previous report was showed that an AGS reactor bioaugmented with a 2-fluorophenol degrading strain 
was successful to degrade the contaminant [12]. That strain does not rely on co-metabolism and likely this 
difference is the main reason for the observed differences. The inefficiency in the diclofenac removal on 
SBR is in accordance with the results obtained by He et al.  [35], in which it was observed a removal of 
11.7% of 1 µg L-1 in a SBR seeded with activated sludge. On the other hand, removal of diclofenac (1 mg 
L-1) was achieved by fungal granules but with a cycle length of 1 day and in co-metabolism with 10 g L-1 
of glucose [36]. Diclofenac removal efficiencies of 65% and 55% were observed in respirometric assays 
using activated sludge with 1 and 10 μg/L of diclofenac, respectively, and dominance of heterotrophic 
biomass on the removal [37]. 
Over the past years, several researchers assessed the ability of different bioreactors for diclofenac 
degradation. Nguyen et al.  [38] evaluated the removal of diclofenac using a membrane bioreactor, 
resulting in 4-26% removal; the addition of granular activated carbon (GAC) improved the removal to 
96% through adsorption onto GAC. A moving bed biofilm reactor (MBBR) was used for the removal of 
pharmaceuticals from wastewater [39]. The reactor itself accounted for 74-85% of diclofenac removal. 
When the MBBR was coupled with hydrodynamic cavitation/hydrogen peroxide process and UV 
treatment, diclofenac removal increased to 98% [39]. Another study explored the use of aerated biofilters 
with manganese feeding, which resulted in an efficient diclofenac removal, but with a long adaptation 
time (ca. 1 year) [40]. Lonappan and co-workers  [33] investigated the removal of diclofenac through 
adsorption onto micro-biochar fixed bed column with ca. 70% of removal achieved. The above-
mentioned studies report diclofenac removal mainly through adsorption and not through biodegradation.  
In fact, diclofenac removal through adsorption has been reported in several studies, using activated 
carbon [41,42], graphene oxide nanosheets [43], composite low-cost material [44] and biphasic apatite-
carbon biochar-type materials prepared from pyrolysed cod fish bones [45]. Further combined strategies 
are needed to effectively remove pharmaceuticals such as diclofenac from wastewater. 
 
3.2. Granular biomass properties 
The bed volume and TSS were measured during the different operational conditions applied to the 
bioreactor as shown in Fig. 4. High values of TSS in the effluent were observed during phase II, 
corresponding to the granulation period, in which settling times were gradually decreased. As the settling 
time remained at 3 min, only particles with a settling velocity larger than 6 m h-1 were effectively retained 
in the reactor, concomitantly TSS showed a substantial decrease (0.56 g L-1), maintaining average values 
of 0.17 g L-1 until the end of the reactor operation. By the end of stage II, mature and stable granules were 
observed (Fig 5). From previous studies, granulation process usually takes ca. 1 month [46] . In the 
current study, granulation period was longer probably due to the constant presence of diclofenac. 
Diclofenac may exhibit inhibitory effects on bacterial communities, mainly due to its ability to inhibit 
DNA synthesis [47]. The selective pressure imposed by diclofenac on the seed sludge during the 
acclimatization period aimed at maintaining the metabolism of the degrading strain and at the same time 
to select for a microbial community that was able to proliferate in the presence of the compound.  
Acclimatization strategies were found to be positive in previous studies on the degradation of toxic 
compounds by AGS [16–19,48]. That strategy was kept during phase II in order to evaluate the effect of 
diclofenac on the granulation process. Albeit a longer granulation period was required, stable and mature 
granules were obtained under the imposed selective pressure. 
The bed volume remained constant during phases II, III and VI (19 cm in average). In Phases IV and V, a 
decrease was observed corresponding to periods of diclofenac intermittent feeding. Table 2 summarizes 
the physical characteristics of AGS during reactor operation. At the beginning of SBR operation (Phase 
II) MLVSS was in average 3.0 g L-1, with an increase when diclofenac was removed from the feeding 
(Phase III) with a concomitant increase of the SRT. When feeding with diclofenac returned (Phase IV), 
the biomass concentration decreased drastically (2.7 g L-1), decreasing even further on Phase V (0.75 g L-
1), accompanied by a decrease of the SRT. After diclofenac feeding stopped (Phase VI) an increase 
occurred (1.4 g L-1), but not reaching the initial values. The activity of biomass (represented by the ratio 
between MLVSS and MLSS) suffered a slight decrease from Phases IV to V. SVI5 demonstrated an 
increasing trend along bioreactor operation, strengthening AGS compressibility and settleability.  
A high biomass concentration was observed along the first phases of the reactor operation, with the 
lowest biomass concentration being recorded when an increase in aeration phase occurred, leading to an 
increase in turbulence inside the reactor which may lead to breaking of the granules causing biomass 
losses during effluent washout. Similar results were observed previously [15]. Nevertheless, biomass 
activity remained constant throughout the whole experiment, even during diclofenac exposure or longer 
aeration times, indicating that the presence of active biomass in the biorreactor was maintained. A decline 
in AGS settling properties was observed when longer aeration times were settled with an upward trend in 
SVI5. Similar results were observed in previous reports dealing with chiral pharmaceuticals [31]. 
3.3. Bacterial community of the AGS-SBR 
3.3.1. Capacity of bacterial isolates recovered from the AGS to degrade diclofenac 
From phases III and VI bacterial strains able to degrade diclofenac were isolated and identified (Table 3). 
A total of eleven bacterial isolates were retrieved from agar plates containing diclofenac, with three 
strains affiliated with α-Proteobacteria, two with β-Proteobacteria, three with γ-Proteobacteria, two with 
Actinobacteria and one with Bacteroidetes. The majority of the culturable isolates were from the 
Proteobacteria group, which is in accordance with previous studies [49]. Most of the isolates were 
closely related to environmental samples (soil, river water, groundwater, coal) as well as wastewater 
treatment plants. Labrys portucalensis strain F11 was not recovered through this approach. The capacity 
of each isolate to use diclofenac (9.54 mg L-1) as a sole carbon source was tested in liquid batch mode for 
30 days. Their degradation ability (in percentage) is presented in Table 3. The highest degradation 
obtained was 33.5%, that was about half of the extent achieved by Labrys portucalensis F11 for the same 
diclofenac concentration supplied as a sole carbon source [23]. No decrease in diclofenac concentration 
was registered in control assays (data not shown), demonstrating that neither adsorption nor abiotic 
degradation occurred under the tested conditions.  
3.3.2. Molecular analysis of bacterial communities of the AGS-SBR  
The variations in the bacterial community in AGS, collected along the SBR operation, were investigated 
by DGGE of 16S rRNA gene (Fig. 6). The DGGE patterns showed a dynamic bacterial microbial 
community during bioreactor operation. A total of 176 distinct bands were retrieved, with the number of 
DGGE bands per lane varied between 13 and 22, indicating a wide bacterial diversity within the granules. 
One band was present in every sample (band b3) while others were only present in specific sampling days 
(bands b1, b2, b8 and b20) (Fig. 6). 
A cluster analysis (Fig. 7) showed that the bacterial assemblages present two main branches separating 
the samples from the phases I and II from those taken from phases III – VI. The first branch clearly shows 
the sludge acclimatization to diclofenac and the granulation phase with samples collected from days 0 and 
20 (during acclimatization process) showing less than 30% of similarity. When the operation mode was 
changed from bubble column to SBR mode (day 20) a slightly change in the microbial community was 
observed as the similarities between day 20 and 26 were 75%. A more pronounced effect was observed 
during the granules formation (phase II), between days 26 and 40 (less than 30% similarity) and between 
days 40 and 68 (ca. 55% similarity), indicating a re-structuring of the community imposed by the 
decreasing settling time and the concomitant granule formation and that the formed matured granules 
were constituted by an adapted microbial population. The second branch can be sub-divided in two: one 
that combines days 110 and 142, representing phase III, where no diclofenac was being loaded to the 
bioreactor, and the second sub-branch including phases V and VI. Dynamic microbial community of 
AGS-SBR with major shift attributed to continuous feeding with pharmaceuticals was reported by 
Amorim et al.  [50]. 
Numerical analysis of DGGE profiles (Fig. 7) showed that the Shannon’s diversity index (H) varied 
between 0.70 and 1.22. A higher species abundance and diversity (H) were obtained on phase III when 
diclofenac was not fed into the reactor, probably indicating that some species in the granules were 
inhibited when diclofenac was present. The Equitability index (E) varied between 0.60 and 0.94 (days 
286 and 26, respectively), indicating an increase in dominance of some species by the end of the 
experiment. The lowest H and E values were obtained on the last experimental day, suggesting a low 
species diversity but with a high dominance, even after diclofenac has being removed from the inlet 30 
days before, reinforcing the pressure exerted from this micropollutant on microbial communities.  
Selected DGGE bands (Fig. 6) were excised for direct PCR amplification followed by DNA sequencing. 
Partial 16S rRNA gene sequences were successfully obtained from twenty-one DGGE bands (b1 – b21 in 
Fig. 6) and compared with nucleotide sequences from GenBank (Table 4). According to its presence 
along the reactor operation, the most predominant phyla was Proteobacteria (subclasses β > α ≈ γ) and 
uncultured organisms followed by Bacteroidetes and Firmicutes,  obtained from environmental samples, 
such as sediments, but also from treatment plants and even drinking water, which is in accordance with 
previous reports on aerobic granules microbial population [51]. Thauera sp. (accession nº LC145286 and 
nº MH665743) was present in all samples from the granule formation phase (phase II). It is known that 
the genus Thauera sp. is involved in microbial aggregation and granule stability as they are able to 
produce exopolysaccharides (EPS) which strengths the microbial core [52]. Its presence during phase III 
can be related to its ability to remove organic compounds, such as acetate, as previously demonstrated by 
Liu et al.,  [54]. Bands 3, 11 and 29 presented a high similarity (99%) with the degrading strain Labrys 
portucalensis F11 and its presence was maintained throughout the entire reactor operation (on Table 4, 
bands 3, 11 and 21). This is an evidence of the success of the bioaugmentation strategy adopted for the 
incorporation of the selected strain into the granules.  
3.3.3. Capacity of AGS to degrade diclofenac in batch mode 
Batch liquid cultures containing aerobic granules and 0.03 mM of diclofenac were established to 
investigate their diclofenac biodegradation ability. At the same time, adsorption assays were conducted. 
The diclofenac removal achieved is presented in Fig. 8. During the first 9 days, diclofenac concentration 
decreased very slowly in biodegradation assays, however after the second feeding with acetate (day 14), 
the degradation increased, The DCF degradation rate constant (0.042±0.0006 d-1) was well fitted to the 
first-order kinetics (the value of R2 = 0.96). By the end of the experiment, 72% of the diclofenac fed was 
removed, indicating the ability of AGS to degrade the pharmaceutical compound in cometabolism with 
acetate (Fig. 8). On control assays with inactivated granules (Fig. 8), some adsorption of diclofenac onto 
granules was observed during the first 10 days, after which desorption started to occur, reaching the initial 
diclofenac concentration in the liquid by the end of the experiment. No granules disintegration was 
observed during the experimental period. Also, no decrease in DCF concentration was observed in biotic 
and abiotic control assays. The granules from the reactor showed the ability to degrade diclofenac at 
higher degradation rates than the culturable isolated strains, reinforcing the contribution of the 
bioaugmented Labrys portucalensis F11 for the obtained results.  
 
4. Conclusions 
In the present study, introduction of diclofenac for a long period in the feeding of an established AGS-
SBR bioaugmented with a strain able to biodegrade the target micropollutant did not cause a negative 
impact on its main biological functions. COD, phosphate and ammonia removal were not affected by the 
presence of the diclofenac, demonstrating the robustness facing the presence of micropollutants. Nitrite 
oxidizing bacteria demonstrated its ability of adaptation to the micropollutant and recover activity. A 
dynamic microbial community during AGS-SBR operation was observed. Bioaugmentation with a strain 
able to biodegrade diclofenac was successful from the point of view of establishing specialized granules 
within AGS reactor, even though the short length of reaction time imposed by the cycle duration did not 
allow for the removal of the pharmaceutical compound.   
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Fig. 1 (a) COD (mgO2 L
-1), (b) [PO4
2--P] (mg L-1), (c) [NH4
+-N] (mg L-1), (d) [NO2
--N] (mg L-1) and (e) 
[NO3
--N] (mg L-1) concentration profiles during SBR operation. Concentrations in the Inlet (▲), one hour 
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Fig. 2 (a) [PO4
2--P] (mg L-1) (diamonds) and (b) [NH4
+-N] (mg L-1) (circles), [NO2
--N] (mg L-1) 
(triangles) and [NO3
--N] (mg L-1) (squares) profiles along AGS-SBR operation. Filled symbols represent 
a cycle with diclofenac feeding from day 194 until day 233 and empty symbols a cycle thereafter (from 




Fig. 3 Diclofenac concentration (mg L-1) profile along AGS-SBR operation (Phase V). 
 
 
Fig. 4 Profile of the bed volume and TSS of the effluent during AGS-SBR operation. Columns represent 
the bed volume whereas data points represent TSS in the effluent (●). Values are means ± standard error 
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Fig. 6 DGGE community fingerprint of the SBR 16S rRNA gene population along AGS-SBR operation. 
The collection day is indicated above each lane. Lane M: DNA marker. Bands that were excised for 












Fig. 7 Cluster analysis of bacterial communities of AGS-SBR based upon DGGE profiles and Shannon 
diversity (H) and Equitability (E) indexes. Similarities were calculated using the Jaccard coefficient. The 
dendrogram presents the similarity, in percentage, between the DGGE samples. Numbers at nodes 
represent the cophenetic correlation coefficient values. The H and E indexes calculated for each sample 




Fig. 8 Diclofenac degradation profile during batch assays using AGS. Bars indicate the percentage of 






























































feeding with acetate and filled circles indicate diclofenac concentration on an adsorption control assay 
with inactivated granules (●). Values are means ± standard error of the mean (SEM). 
















Inlet Carbon sources 
Concentrations (mM) 
Acetate DCF 
I 0 - 19 20 180 - 180 5.9 0.03 
II 20 - 97 78 180 60 85 5.9 0.03 
III 98 - 193 96 180 60 112 5.9 0 
IV a 194-228 35 180 60 112 5.9 0.03 
V a 229 - 256 28 360 60 292 5.9 0.03 
VI 257 - 286 30 360 60 292 5.9 0 
a
 DCF applied 1cycle/48hrs. 
      
Table 2. Aerobic granular sludge properties along bioreactor operation. 
Phase MLSS (g L
-1
) MLVSS (g L-1) MLVSS/MLSS SVI5 (ml/gSST
-1
) SRT (d) 
II 30.6 ND ND 22.0 ND 
III 32.4 ND ND 21.8 ND 
IV 16.2 15.2 0.94 18.8 18.3 
V 7.79 5.90 0.76 49.6 30.8 
VI 14.6 ND ND 53.1 ND 
MLSS, mixed liquor suspended solids; MLVSS, mixed liquor volatile suspended solids; SRT, sludge retention time; 




Table 3. Phylogenetic affiliation and similarity to the closest relative of bacterial isolates extrated from the aerobic granules
SBR_1 MT193506 Actinobacteria Microbacterium hominis  strain SJTG1 (MH180761) 99 n. d. 22
SBR_2 MT193507 α-Proteobacteria Starkeya  sp. SBR22(KC936274) 100 aerobic granular sludge reactor 28
SBR_3 MT193508 γ - Proteobacteria Serratia  sp. NB2 (HQ917058) 100 nitrobenzene-contaminated soil 27
SBR_4 MT193509 Actinobacteria Rhodococcus qingshengii strain S521B-49 (HQ238487) 100 fermenting grain 19
SBR_5 MT193510 Bacteroidetes Flavobacteriaceae bacterium  HJX21 (KP979552) 99 river water 34
SBR_6 MT193511 α-Proteobacteria Rhizobium sp. HW-2 (KP152651) 99 coal 33
SBR_7 MT193512 γ - Proteobacteria Pseudomonas sp. strain Gamma-81 (MH703512) 99 soil 25
SBR_8 MT193513 γ - Proteobacteria Pseudoxanthomonas  sp. strain DMAJP25 (KX817875) 99 soil 33
SBR_9 MT193514 β - Proteobacteria Chitinimonas taiwanensis  strain fA3 (FJ947053) 99 sewage of a waste water treatment plant 27
SBR_10 MT193515 β - Proteobacteria Acidovorax  sp. strain R022 (MH569472) 100 groundwater 25
SBR_11 MT193516 α-Proteobacteria Rhizobiales  bacterium ROi51 (EF219048) 99 membrane  biofilms treating MBR effluent 20










Closest relative (accession nr.)
 
 
Table 4. Phylogenetic affiliation and similarity to the closest relative of bacterial strains isolated from SBR
I II III V VI
b1 Unknown Uncultured bacterium clone OTU 89 (KX652496) 97 n.d. √
b2 β - Proteobacteria Uncultured beta proteobacterium  (KC633461) 100 activated sludge of a full-scale WWTP √
b3 α-Proteobacteria Labrys portucalensis  strain F11 (AY362040.1) 99 contaminated sediment √ √ √ √ √
b4 Unknown Uncultured bacterium clone PHA88 (JQ658336.1) 97 PHA-accumulating mix culture √ √
b5 γ - Proteobacteria Azomonas macrocytogenes  strain ICMP 4308 (EF122433) 0.99 n.d. √
b6 β - Proteobacteria Thauera  sp. LOPT-10-14 gene (LC145286) 100 wastewater treatment plant √ √
b7 Unknown Uncultured bacterium isolate (KU258296) 97 A2O reactor √
b8 β - Proteobacteria Thauera aromatica  strain M11 (MH665743) 96 n.d. √
b9 Bacteroidetes Uncultured Chitinophagaceae bacterium clone 3c_35699 (MG803158) 96 sewage sludge √ √ √ √
b10 Firmicutes Uncultured Dialister sp. isolate DGGE gel band G32 (KU877511) 89 fecal sample √
b11 α-Proteobacteria Labrys portucalensis  strain F11 (AY362040.1) 99 contaminated sediment √ √ √ √ √
b12 Unknown Uncultured bacterium clone MABRDTU39 (FJ529992) 79 counter-diffusion biofilm √ √ √
b13 β - Proteobacteria Uncultured Nitrosomona s sp. clone isolate DGGE gel band (MH333199.1) 92 Nitrifying MBR √ √ √
b14 Bacteroidetes Uncultured Niabella  sp. (MG803287) 96 sewage sludge √ √
b15 Bacteroidetes Bacteroidetes bacterium MA051 (FJ377378) 97 n.d. √ √ √
b16 γ - Proteobacteria Lysobacter  sp. strain WW223 (MH591530) 100 Well Water √ √
b17 Firmicutes Uncultured Dialister  sp.(KU877511) 88 n.d. √ √
b18 β - Proteobacteria Uncultured beta proteobacterium  (HE856422) 87 microbial fuel cell √ √
b19 Unknown Uncultured bacterium clone Sample_1C1_Contig_23 (KJ633531) 82 waste deposit soil sample √ √
b20 γ - Proteobacteria Tahibacter aquaticus  (AM981202) 98 drinking water network
b21 α-Proteobacteria Labrys portucalensis  strain F11 (AY362040.1) 99 contaminated sediment √ √ √ √ √





Closest relative (accession nr.)
Similarity 
(% )
Isolation source
